Molgramostim/hyaluronan/sucralfate(Reponex Pharmaceuticals)

N/A

Report date: 2024/11/06 17:09:14

Base Information

Drug NameMolgramostim/hyaluronan/sucralfate(Reponex Pharmaceuticals)
Drug Alias NameRNX-022
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulantsHyaluronic acid modulators
TargetsHyaluronic acidGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsWounds and InjuriesVaricose Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesReponex Pharmaceuticals As
China Registration ClassN/A

Develop Information

Active CompaniesReponex Pharmaceuticals As
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesVaricose Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A